Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?Emmanuel Acheampong(Edith Cowan University), Elin S. Gray(Edith Cowan University)CancersJune 30, 201910.3390/cancers11070920Cited by 12SaveCiteExport RISWatch citationsRelated PapersCirculating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma|Oncotarget|2015|327Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis|Cells|2020|72